Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance.

Lampasona V, Pittman DL, Williams AJ, Achenbach P, Schlosser M, Akolkar B, Winter WE; Participating Laboratories.

Clin Chem. 2019 Aug 13. pii: clinchem.2019.304196. doi: 10.1373/clinchem.2019.304196. [Epub ahead of print]

PMID:
31409598
2.

Birth and coming of age of islet autoantibodies.

Bonifacio E, Achenbach P.

Clin Exp Immunol. 2019 Aug 9. doi: 10.1111/cei.13360. [Epub ahead of print] Review.

PMID:
31397889
3.

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol.

Ziegler AG, Achenbach P, Berner R, Casteels K, Danne T, Gündert M, Hasford J, Hoffmann VS, Kordonouri O, Lange K, Elding Larsson H, Lundgren M, Snape MD, Szypowska A, Todd JA, Bonifacio E; and the GPPAD Study group.

BMJ Open. 2019 Jun 28;9(6):e028578. doi: 10.1136/bmjopen-2018-028578.

4.

Age, HLA, and Sex Define a Marked Risk of Organ-Specific Autoimmunity in First-Degree Relatives of Patients With Type 1 Diabetes.

Winkler C, Jolink M, Knopff A, Kwarteng NA, Achenbach P, Bonifacio E, Ziegler AG.

Diabetes Care. 2019 Sep;42(9):1684-1691. doi: 10.2337/dc19-0315. Epub 2019 Jun 18.

PMID:
31213469
5.

Fibroadhesive scarring of grafted collagen scaffolds interferes with implant-host neural tissue integration and bridging in experimental spinal cord injury.

Altinova H, Hammes S, Palm M, Gerardo-Nava J, Achenbach P, Deumens R, Hermans E, Führmann T, Boecker A, van Neerven SGA, Bozkurt A, Weis J, Brook GA.

Regen Biomater. 2019 Mar;6(2):75-87. doi: 10.1093/rb/rbz006. Epub 2019 Feb 4.

6.

Harmonization of immunoassays for biomarkers in diabetes mellitus.

Hörber S, Achenbach P, Schleicher E, Peter A.

Biotechnol Adv. 2019 Feb 23. pii: S0734-9750(19)30034-5. doi: 10.1016/j.biotechadv.2019.02.015. [Epub ahead of print] Review.

7.

Time-Resolved Autoantibody Profiling Facilitates Stratification of Preclinical Type 1 Diabetes in Children.

Endesfelder D, Zu Castell W, Bonifacio E, Rewers M, Hagopian WA, She JX, Lernmark Å, Toppari J, Vehik K, Williams AJK, Yu L, Akolkar B, Krischer JP, Ziegler AG, Achenbach P; TEDDY Study Group.

Diabetes. 2019 Jan;68(1):119-130. doi: 10.2337/db18-0594. Epub 2018 Oct 10.

8.

Immunological biomarkers for the development and progression of type 1 diabetes.

Mathieu C, Lahesmaa R, Bonifacio E, Achenbach P, Tree T.

Diabetologia. 2018 Nov;61(11):2252-2258. doi: 10.1007/s00125-018-4726-8. Epub 2018 Sep 12. Review.

PMID:
30209538
9.

Recruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention study.

Kick K, Assfalg R, Aydin S, Bechtold-Dalla Pozza S, Böcker D, Braig S, Bunk M, Dunstheimer D, Durmashkina A, Ermer U, Gavazzeni A, Gerstl EM, Heinrich M, Herbst M, Kriesen Y, Kuhnle-Krahl U, Müller H, Nellen-Hellmuth N, Ockert C, Ramminger C, Sindichakis M, Tretter S, Warncke K, Achenbach P, Ziegler AG, Hoffmann VS.

Contemp Clin Trials Commun. 2018 Aug 15;11:170-173. doi: 10.1016/j.conctc.2018.08.004. eCollection 2018 Sep.

10.

Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes.

Heinrich M, Maison N, Achenbach P, Assfalg R, Braig S, Böcker D, Dunstheimer D, Ermer U, Gavazzeni A, Gerstl EM, Hummel S, Kick K, Müller H, Nellen-Hellmuth N, Ockert C, Sindichakis M, Tretter S, Warncke K, Ziegler AG, Beyerlein A; Fr1da-Study group.

Pediatr Diabetes. 2018 Nov;19(7):1238-1242. doi: 10.1111/pedi.12739. Epub 2018 Sep 3.

PMID:
30098103
11.

First Measurement of the Q^{2} Dependence of the Beam-Normal Single Spin Asymmetry for Elastic Scattering off Carbon.

Esser A, Thiel M, Achenbach P, Aulenbacher K, Baunack S, Beričič J, Bosnar D, Correa L, Dehn M, Distler MO, Fonvieille H, Friščić I, Gorchtein M, Heidrich S, Herrmann P, Hoek M, Kegel S, Kohl Y, Kolar T, Kreidel HJ, Maas FE, Merkel H, Mihovilovič M, Müller J, Müller U, Nillius F, Palatchi C, Paschke KD, Pochodzalla J, Schlimme BS, Schoth M, Schulz F, Širca S, Spruck B, Štajner S, Tioukine V, Tyukin A, Weber A, Sfienti C.

Phys Rev Lett. 2018 Jul 13;121(2):022503. doi: 10.1103/PhysRevLett.121.022503.

PMID:
30085726
12.

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.

Tavira B, Barcenilla H, Wahlberg J, Achenbach P, Ludvigsson J, Casas R.

J Diabetes Res. 2018 May 24;2018:9391845. doi: 10.1155/2018/9391845. eCollection 2018.

13.

Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.

Achenbach P, Hawa MI, Krause S, Lampasona V, Jerram ST, Williams AJK, Bonifacio E, Ziegler AG, Leslie RD; Action LADA consortium.

Diabetologia. 2018 Jul;61(7):1644-1649. doi: 10.1007/s00125-018-4605-3. Epub 2018 Apr 4.

14.

The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.

Wyatt RC, Brigatti C, Liberati D, Grace SL, Gillard BT, Long AE, Marzinotto I, Shoemark DK, Chandler KA, Achenbach P, Gillespie KM, Piemonti L, Lampasona V, Williams AJK.

Diabet Med. 2018 Jul;35(7):954-963. doi: 10.1111/dme.13628. Epub 2018 Apr 19.

PMID:
29577424
15.

Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.

Long AE, Wilson IV, Becker DJ, Libman IM, Arena VC, Wong FS, Steck AK, Rewers MJ, Yu L, Achenbach P, Casas R, Ludvigsson J, Williams AJK, Gillespie KM.

Diabetologia. 2018 Jun;61(6):1484-1490. doi: 10.1007/s00125-018-4591-5. Epub 2018 Mar 12.

16.

A novel LIPS assay for insulin autoantibodies.

Liberati D, Wyatt RC, Brigatti C, Marzinotto I, Ferrari M, Bazzigaluppi E, Bosi E, Gillard BT, Gillespie KM, Gorus F, Weets I, Balti E, Piemonti L, Achenbach P, Williams AJK, Lampasona V.

Acta Diabetol. 2018 Mar;55(3):263-270. doi: 10.1007/s00592-017-1082-y. Epub 2018 Jan 5.

PMID:
29305766
17.

A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes.

Serr I, Scherm MG, Zahm AM, Schug J, Flynn VK, Hippich M, Kälin S, Becker M, Achenbach P, Nikolaev A, Gerlach K, Liebsch N, Loretz B, Lehr CM, Kirchner B, Spornraft M, Haase B, Segars J, Küper C, Palmisano R, Waisman A, Willis RA, Kim WU, Weigmann B, Kaestner KH, Ziegler AG, Daniel C.

Sci Transl Med. 2018 Jan 3;10(422). pii: eaag1782. doi: 10.1126/scitranslmed.aag1782. Erratum in: Sci Transl Med. 2019 Feb 20;11(480):.

18.

Beam-Recoil Polarization Measurement of π^{0} Electroproduction on the Proton in the Region of the Roper Resonance.

Štajner S, Achenbach P, Beranek T, Beričič J, Bernauer JC, Bosnar D, Böhm R, Correa L, Denig A, Distler MO, Esser A, Fonvieille H, Friedrich JM, Friščić I, Kegel S, Kohl Y, Merkel H, Mihovilovič M, Müller J, Müller U, Nungesser L, Pochodzalla J, Schlimme BS, Schoth M, Schulz F, Sfienti C, Širca S, Thiel M, Tiator L, Tyukin A, Weber A, Yaron I; A1 Collaboration.

Phys Rev Lett. 2017 Jul 14;119(2):022001. doi: 10.1103/PhysRevLett.119.022001. Epub 2017 Jul 13.

PMID:
28753336
19.

Peptide serum markers in islet autoantibody-positive children.

von Toerne C, Laimighofer M, Achenbach P, Beyerlein A, de Las Heras Gala T, Krumsiek J, Theis FJ, Ziegler AG, Hauck SM.

Diabetologia. 2017 Feb;60(2):287-295. doi: 10.1007/s00125-016-4150-x. Epub 2016 Nov 4.

PMID:
27815605
20.

3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD65, to IA-2 and to ZnT8.

Amoroso M, Achenbach P, Powell M, Coles R, Chlebowska M, Carr L, Furmaniak J, Scholz M, Bonifacio E, Ziegler AG, Rees Smith B.

Clin Chim Acta. 2016 Nov 1;462:60-64. doi: 10.1016/j.cca.2016.08.013. Epub 2016 Aug 26.

PMID:
27570064
21.

Insight into the Narrow Structure in η Photoproduction on the Neutron from Helicity-Dependent Cross Sections.

Witthauer L, Dieterle M, Abt S, Achenbach P, Afzal F, Ahmed Z, Annand JR, Arends HJ, Bashkanov M, Beck R, Biroth M, Borisov NS, Braghieri A, Briscoe WJ, Cividini F, Costanza S, Collicott C, Denig A, Downie EJ, Drexler P, Ferretti-Bondy MI, Gardner S, Garni S, Glazier DI, Glowa D, Gradl W, Günther M, Gurevich GM, Hamilton D, Hornidge D, Huber GM, Käser A, Kashevarov VL, Kay S, Keshelashvili I, Kondratiev R, Korolija M, Krusche B, Lazarev AB, Linturi JM, Lisin V, Livingston K, Lutterer S, MacGregor IJ, Mancell J, Manley DM, Martel PP, Metag V, Meyer W, Miskimen R, Mornacchi E, Mushkarenkov A, Neganov AB, Neiser A, Oberle M, Ostrick M, Otte PB, Paudyal D, Pedroni P, Polonski A, Prakhov SN, Rajabi A, Reicherz G, Ron G, Rostomyan T, Sarty A, Sfienti C, Sikora MH, Sokhoyan V, Spieker K, Steffen O, Strakovski II, Strub T, Supek I, Thiel A, Thiel M, Thomas A, Unverzagt M, Usov YA, Wagner S, Walford NK, Watts DP, Werthmüller D, Wettig J, Wolfes M, Zana L; A2 Collaboration at MAMI.

Phys Rev Lett. 2016 Sep 23;117(13):132502. Epub 2016 Sep 22.

PMID:
27715117
22.

3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary Blood.

Ziegler AG, Haupt F, Scholz M, Weininger K, Wittich S, Löbner S, Matzke C, Gezginci C, Riethausen S, Beyerlein A, Zillmer S, Amoroso M, Coles R, Powell M, Furmaniak J, Smith BR, Winkler C, Bonifacio E, Achenbach P.

Diabetes Technol Ther. 2016 Nov;18(11):687-693. Epub 2016 Aug 23.

PMID:
27552135
23.

A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.

Endesfelder D, Hagen M, Winkler C, Haupt F, Zillmer S, Knopff A, Bonifacio E, Ziegler AG, Zu Castell W, Achenbach P.

Diabetologia. 2016 Oct;59(10):2172-80. doi: 10.1007/s00125-016-4050-0. Epub 2016 Jul 11.

PMID:
27400691
24.

Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study.

Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, Assfalg R, Weininger K, Wittich S, Löbner S, Beyerlein A, Nennstiel-Ratzel U, Lang M, Laub O, Dunstheimer D, Bonifacio E, Achenbach P, Winkler C, Ziegler AG; Fr1da Study Group.

BMJ Open. 2016 May 18;6(5):e011144. doi: 10.1136/bmjopen-2016-011144.

25.

[Early diagnosis, early care--"Fr1da" screening of children for type 1 diabetes].

Puff R, Haupt F, Winkler C, Assfalg R, Achenbach P, Ziegler AG.

MMW Fortschr Med. 2016 Mar 3;158(4):65-6. doi: 10.1007/s15006-016-7884-y. German. No abstract available.

PMID:
27119891
26.

Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production.

Endesfelder D, Engel M, Davis-Richardson AG, Ardissone AN, Achenbach P, Hummel S, Winkler C, Atkinson M, Schatz D, Triplett E, Ziegler AG, zu Castell W.

Microbiome. 2016 Apr 26;4:17. doi: 10.1186/s40168-016-0163-4.

27.

Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.

Serr I, Fürst RW, Achenbach P, Scherm MG, Gökmen F, Haupt F, Sedlmeier EM, Knopff A, Shultz L, Willis RA, Ziegler AG, Daniel C.

Nat Commun. 2016 Mar 15;7:10991. doi: 10.1038/ncomms10991.

28.

Observation of Λ(4)H Hyperhydrogen by Decay-Pion Spectroscopy in Electron Scattering.

Esser A, Nagao S, Schulz F, Achenbach P, Ayerbe Gayoso C, Böhm R, Borodina O, Bosnar D, Bozkurt V, Debenjak L, Distler MO, Friščić I, Fujii Y, Gogami T, Hashimoto O, Hirose S, Kanda H, Kaneta M, Kim E, Kohl Y, Kusaka J, Margaryan A, Merkel H, Mihovilovič M, Müller U, Nakamura SN, Pochodzalla J, Rappold C, Reinhold J, Saito TR, Sanchez Lorente A, Sánchez Majos S, Schlimme BS, Schoth M, Sfienti C, Širca S, Tang L, Thiel M, Tsukada K, Weber A, Yoshida K; A1 Collaboration.

Phys Rev Lett. 2015 Jun 12;114(23):232501. Epub 2015 Jun 9.

PMID:
26196794
29.

Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.

Giannopoulou EZ, Winkler C, Chmiel R, Matzke C, Scholz M, Beyerlein A, Achenbach P, Bonifacio E, Ziegler AG.

Diabetologia. 2015 Oct;58(10):2317-23. doi: 10.1007/s00125-015-3672-y. Epub 2015 Jul 3.

PMID:
26138334
30.

Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes.

Williams AJ, Lampasona V, Wyatt R, Brigatti C, Gillespie KM, Bingley PJ, Achenbach P.

Diabetes. 2015 Sep;64(9):3247-52. doi: 10.2337/db14-1694. Epub 2015 May 22.

31.

Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes.

Williams AJ, Lampasona V, Schlosser M, Mueller PW, Pittman DL, Winter WE, Akolkar B, Wyatt R, Brigatti C, Krause S, Achenbach P; Participating Laboratories.

Diabetes. 2015 Sep;64(9):3239-46. doi: 10.2337/db14-1693. Epub 2015 May 13.

32.

Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.

Bonifacio E, Ziegler AG, Klingensmith G, Schober E, Bingley PJ, Rottenkolber M, Theil A, Eugster A, Puff R, Peplow C, Buettner F, Lange K, Hasford J, Achenbach P; Pre-POINT Study Group.

JAMA. 2015 Apr 21;313(15):1541-9. doi: 10.1001/jama.2015.2928.

PMID:
25898052
33.

[Type 1 diabetes mellitus. Early detection and prevention].

Hummel M, Achenbach P.

Internist (Berl). 2015 May;56(5):475-83. doi: 10.1007/s00108-014-3626-3. German.

PMID:
25894242
34.

Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screening.

Chmiel R, Giannopoulou EZ, Winkler C, Achenbach P, Ziegler AG, Bonifacio E.

Diabetologia. 2015 Feb;58(2):411-3. doi: 10.1007/s00125-014-3443-1. Epub 2014 Nov 20. No abstract available.

PMID:
25409656
35.

Search at the Mainz Microtron for light massive gauge bosons relevant for the muon g-2 anomaly.

Merkel H, Achenbach P, Ayerbe Gayoso C, Beranek T, Beričič J, Bernauer JC, Böhm R, Bosnar D, Correa L, Debenjak L, Denig A, Distler MO, Esser A, Fonvieille H, Friščić I, Gómez Rodríguez de la Paz M, Hoek M, Kegel S, Kohl Y, Middleton DG, Mihovilovič M, Müller U, Nungesser L, Pochodzalla J, Rohrbeck M, Ron G, Sánchez Majos S, Schlimme BS, Schoth M, Schulz F, Sfienti C, Sirca S, Thiel M, Tyukin A, Weber A, Weinriefer M; (A1 Collaboration).

Phys Rev Lett. 2014 Jun 6;112(22):221802. Epub 2014 Jun 4.

PMID:
24949757
36.

GAD autoantibody affinity in schoolchildren from the general population.

Bender C, Schlosser M, Christen U, Ziegler AG, Achenbach P.

Diabetologia. 2014 Sep;57(9):1911-8. doi: 10.1007/s00125-014-3294-9. Epub 2014 Jun 18.

PMID:
24939430
37.

[Predisposition, early stages and phenotypes of type 1 diabetes].

Achenbach P, Winkler C, Haupt F, Beyerlein A, Ziegler AG.

Dtsch Med Wochenschr. 2014 May;139(21):1100-4. doi: 10.1055/s-0034-1370059. Epub 2014 May 13. Review. German. No abstract available.

PMID:
24823976
38.

[Phenotypes of diabetes mellitus and its clinical significance].

Achenbach P, Ziegler AG.

Dtsch Med Wochenschr. 2014 May;139(21):1095-6. doi: 10.1055/s-0034-1370089. Epub 2014 May 13. German. No abstract available.

PMID:
24823974
39.

Compromised gut microbiota networks in children with anti-islet cell autoimmunity.

Endesfelder D, zu Castell W, Ardissone A, Davis-Richardson AG, Achenbach P, Hagen M, Pflueger M, Gano KA, Fagen JR, Drew JC, Brown CT, Kolaczkowski B, Atkinson M, Schatz D, Bonifacio E, Triplett EW, Ziegler AG.

Diabetes. 2014 Jun;63(6):2006-14. doi: 10.2337/db13-1676. Epub 2014 Mar 7.

40.

GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.

Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P.

Diabetes Care. 2014 Jun;37(6):1675-80. doi: 10.2337/dc13-1719. Epub 2014 Mar 5.

PMID:
24598244
41.

A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.

Ferreira RC, Guo H, Coulson RM, Smyth DJ, Pekalski ML, Burren OS, Cutler AJ, Doecke JD, Flint S, McKinney EF, Lyons PA, Smith KG, Achenbach P, Beyerlein A, Dunger DB, Clayton DG, Wicker LS, Todd JA, Bonifacio E, Wallace C, Ziegler AG.

Diabetes. 2014 Jul;63(7):2538-50. doi: 10.2337/db13-1777. Epub 2014 Feb 21.

42.

Measurement of the neutron electric to magnetic form factor ratio at Q2=1.58  GeV2 using the reaction 3He[over →](e[over →],e'n)pp.

Schlimme BS, Achenbach P, Ayerbe Gayoso CA, Bernauer JC, Böhm R, Bosnar D, Challand T, Distler MO, Doria L, Fellenberger F, Fonvieille H, Gómez Rodríguez M, Grabmayr P, Hehl T, Heil W, Kiselev D, Krimmer J, Makek M, Merkel H, Middleton DG, Müller U, Nungesser L, Ott BA, Pochodzalla J, Potokar M, Sánchez Majos S, Sargsian MM, Sick I, Sirca S, Weinriefer M, Wendel M, Yoon CJ.

Phys Rev Lett. 2013 Sep 27;111(13):132504. Epub 2013 Sep 26.

PMID:
24116774
43.

Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes.

Krause S, Beyerlein A, Winkler C, Gavrisan A, Kayser C, Puff R, Bonifacio E, Ziegler AG, Achenbach P.

Acta Diabetol. 2014;51(3):517-8. doi: 10.1007/s00592-013-0512-8. Epub 2013 Sep 5. No abstract available.

PMID:
24006086
44.

HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database.

Awa WL, Boehm BO, Rosinger S, Achenbach P, Ziegler AG, Krause S, Meissner T, Wiegand S, Reinehr T, Kapellen T, Karges B, Eiermann T, Schober E, Holl RW; DPV Initiative and the German BMBF Competence Networks Diabetes Mellitus and Obesity.

Pediatr Diabetes. 2013 Dec;14(8):562-74. doi: 10.1111/pedi.12043. Epub 2013 Apr 30.

PMID:
23627341
45.

Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.

Achenbach P, Hummel M, Thümer L, Boerschmann H, Höfelmann D, Ziegler AG.

Diabetologia. 2013 Jul;56(7):1615-22. doi: 10.1007/s00125-013-2896-y. Epub 2013 Mar 29.

PMID:
23539116
46.

IA-2 autoantibody affinity in children at risk for type 1 diabetes.

Krause S, Chmiel R, Bonifacio E, Scholz M, Powell M, Furmaniak J, Rees Smith B, Ziegler AG, Achenbach P.

Clin Immunol. 2012 Dec;145(3):224-9. doi: 10.1016/j.clim.2012.09.010. Epub 2012 Oct 3.

PMID:
23110943
47.

A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes.

Winkler C, Krumsiek J, Lempainen J, Achenbach P, Grallert H, Giannopoulou E, Bunk M, Theis FJ, Bonifacio E, Ziegler AG.

Genes Immun. 2012 Oct;13(7):549-55. doi: 10.1038/gene.2012.36. Epub 2012 Aug 30.

PMID:
22932816
48.

Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.

Howson JM, Krause S, Stevens H, Smyth DJ, Wenzlau JM, Bonifacio E, Hutton J, Ziegler AG, Todd JA, Achenbach P.

Diabetologia. 2012 Jul;55(7):1978-84. doi: 10.1007/s00125-012-2540-2. Epub 2012 Apr 12.

49.

Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes.

Pflueger M, Seppänen-Laakso T, Suortti T, Hyötyläinen T, Achenbach P, Bonifacio E, Orešič M, Ziegler AG.

Diabetes. 2011 Nov;60(11):2740-7. doi: 10.2337/db10-1652.

50.

Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8.

Lampasona V, Schlosser M, Mueller PW, Williams AJ, Wenzlau JM, Hutton JC, Achenbach P.

Clin Chem. 2011 Dec;57(12):1693-702. doi: 10.1373/clinchem.2011.170662. Epub 2011 Oct 6.

Supplemental Content

Loading ...
Support Center